Clinical Trials Logo

Encephalomalacia clinical trials

View clinical trials related to Encephalomalacia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06027411 Recruiting - Stroke, Ischemic Clinical Trials

Assess the Clinical Effectiveness in AI Prioritising CT Heads

ACCEPT
Start date: March 27, 2024
Phase:
Study type: Observational [Patient Registry]

Non-Contrast Computed Tomography (NCCT) of the head is the most common imaging method used to assess patients attending the Emergency Department (ED) with a wide range of significant neurological presentations including trauma, stroke, seizure and reduced consciousness. Rapid review of the images supports clinical decision-making including treatment and onward referral. Radiologists, those reporting scans, often have significant backlogs and are unable to prioritise abnormal images of patients with time critical abnormalities. Similarly, identification of normal scans would support patient turnover in ED with significant waits and pressure on resources. To address this problem, Qure.AI has worked to develop the market approved qER algorithm, which is a software program that can analyse CT head to identify presence of abnormalities supporting workflow prioritisation. This study will trial the software in 4 NHS hospitals across the UK to evaluate the ability of the software to reduce the turnaround time of reporting scans with abnormalities that need to be prioritised.

NCT ID: NCT00167544 Completed - Premature Birth Clinical Trials

Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants

Start date: November 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether treatment of very preterm infants at high-risk for lung and brain injury with low dose hydrocortisone results in improved pulmonary and neurologic outcomes.